91.93
+3.08
+(3.47%)
As of January 17 at 12:45:22 PM GMT-3. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 22 | 13 | 28 | 27 |
Avg. Estimate | 178.68B | 165.99B | 676.62B | 705.45B |
Low Estimate | 175.97B | 163.44B | 671.67B | 691.54B |
High Estimate | 180.57B | 169.24B | 682.45B | 717.07B |
Year Ago Sales | 171.91B | 159.94B | 642.64B | 676.62B |
Sales Growth (year/est) | 3.94% | 3.78% | 5.29% | 4.26% |
EPS Trend
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
WMT.SN | -- | -- | -- | -- |
S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Overweight to Overweight | 1/21/2025 |
Reiterates | RBC Capital: Outperform to Outperform | 1/15/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 1/10/2025 |
Maintains | Barclays: Overweight to Overweight | 1/9/2025 |
Maintains | Jefferies: Buy to Buy | 12/17/2024 |
Maintains | Tigress Financial: Buy to Buy | 12/13/2024 |